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164disease (3). Physicians should remain cognizant of IgG4-related
disease when evaluating localized or systemic ﬁbrosclerosing
conditions before labeling them “idiopathic.” This has therapeutic
and prognostic implications because glucocorticoids and the anti-
CD20 antibody rituximab are considered effective treatment strat-
egies (3).*Nilay Kumar, MD
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2012;366:539–51.Superiority of Fractional Flow
Reserve Versus Intravascular
Ultrasound for Intermediate
Coronary Stenoses
We read with interest the paper on the FIRST (Fractional Flow
Reserve and Intravascular Ultrasound Relationship) study, which
compared the diagnostic accuracy of intravascular ultrasound
(IVUS) with fractional ﬂow reserve (FFR) in a vast population of
367 intermediate coronary lesions, angiographically deﬁned as 40%
to 80% luminal narrowing (1). In their conclusions, the authors
mainly attributed the weak correlation between IVUS and FFR to
the dependence of FFR on vessel size and propose different
minimal lumen area (MLA) cutoffs on the basis of reference vessel
diameter. We believe there is more to say.
The key concept that drives FFR-based evaluation is that it
takes into account not just the severity of the lesion, but also the
amount of myocardium subtended to it. In a similar population of
213 lesions, we have recently demonstrated that the myocardium at
risk, assessed with the angiographic Jeopardy score, as well as the
presence of collateralized chronic total occlusion in another vessel,
were independent predictors of FFR 0.80 (2). Of note, the
Jeopardy score showed closer correlations with FFR compared with
2-dimensional quantitative coronary angiography, such as MLA or
cross-sectional stenosis. Conversely, vessel diameter provides only
an indirect estimation of the amount of ischemic myocardium
subtended to a stenosis and, for example, does not consider whether
or not the myocardium is viable. In the present study, patients with
previous myocardial infarction accounted for almost one-third of
the total population.The primary role of myocardium at risk explains certain
unwritten rules of FFR. First, as also observed by the authors,
the location of the lesion on the left anterior descendent (LAD)
coronary artery, which generally perfuses a larger amount of
myocardium compared with the left circumﬂex (LCX) and right
coronary artery, is an independent predictor of positive FFR at
multivariate analysis. Second, although the use of anatomical
cutoffs considers a coronary vessel as a pipe in which a ﬁxed stenosis
reduces distal pressure and ﬂow, FFR takes into account the
complexity of coronary circulation distal to the stenosis, being
inﬂuenced by the fundamental contribution of coronary collaterals,
whose presence often is crucial to determine whether or not
myocardium is subjected to ischemia. Finally, the importance of
the amount of myocardium at risk explains why FFR is not just
a diagnostic, but also a prognostic tool.
For all these reasons, as opposed to the authors, we do not hope
that a FAME (Fractional Flow Reserve Versus Angiography for
Multivessel Evaluation)-like trial comparing IVUS versus angio-
graphic guidance would ever be designed. For intermediate coronary
stenoses, we strongly suggest that functional rather than anatomical
assessment should always guide revascularization, and we believe
that the results of the FIRST study are in line with this message.*Alberto Ranieri De Caterina, MD
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Cardiovasc Interv 2013;6:29–36.ReplyWe appreciate the interest Dr. De Caterina and colleagues have
taken in our study (1); and would like to stress a few points
regarding intravascular ultrasound (IVUS) versus fractional ﬂow
reserve (FFR)-guided percutaneous coronary intervention (PCI) as
a diagnostic and therapeutic tool. FFR is a physiological test to
detect ischemia. In essence, this is a combination of lesion severity
and the at-risk myocardium, with no prognostic impact (e.g.,
myocardial infarction and mortality as shown in the FAME 2
[Fractional Flow Reserve Versus Angiography for Multivessel
Evaluation II]) study (2). The literature supports the notion that
routine IVUS use can reduce stent thrombosis and target lesion
revascularization. In addition, IVUS helps to determine lesion
morphology, vessel size, and lesion length, and assists in optimizing
stent selection and deployment (3). Cost constraints have limited
